The detection of increased tumor CD8+ T cell infiltrates that are activated and able to produce IFNγ and GZMB and reduced tumor-associated Tregs when CpG-Stat3 siRNA is added to ICB therapy show that CpG-Stat3 siRNA can serve as an effective adjuvant for ICB. The gene discussed is STAT3; the disease is neoplasm.